THORAZINE IM
What it isIntramuscular D2 and 5-HT2A antagonist with strong H1, alpha-1, and muscarinic blockade; agitation, psychosis, emesis, and hiccups.
Why this oneIts parenteral intractable-hiccup indication is unusual among antipsychotics.
What limits itOrthostatic hypotension can be profound — keep the patient supine; local tissue irritation, antimuscarinic toxicity, and QT prolongation also matter.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Acute schizophrenia/manic states (hospitalized) | Adults | 25 mg IM | Add 25–50 mg IM in 1 h if needed; increase over days | Up to 400 mg every 4–6 h in exceptionally severe cases |
| Nausea and vomiting | Adults | 25 mg IM | 25–50 mg IM every 3–4 h PRN until vomiting stops | |
| Presurgical apprehension | Adults | 12.5–25 mg IM 1–2 h before surgery | ||
| Intractable hiccups / acute intermittent porphyria / tetanus (adjunct) | Adults | 25–50 mg IM (hiccups/tetanus); 25 mg IM TID–QID (porphyria) | ||
| Severe behavioral problems / nausea and vomiting | Children 6 months–12 yr | 0.25 mg/lb IM every 6–8 h PRN | ≤5 yr (≤50 lb): 40 mg/day; 5–12 yr (50–100 lb): 75 mg/day |
Renal Use with caution in renal disease.
Hepatic Use with caution in hepatic disease; increased CNS sensitivity in cirrhosis/hepatic encephalopathy.
Pregnancy Undefined.
Lactation Undefined.
⚠ BOXED WARNING
